
Hematologist/Medical Oncologist @TischCancer @IcahnMountSinai
New York, NY
Joined November 2025
- Tweets34
- Following335
- Followers14
- Likes120
Karishma Rupani, MD, MMSc retweeted
🚨👇🏽🚨 Just in time for some relaxing holiday weekend reading! You can’t know where you’re going unless you look at where you’ve been, and it was so much fun to look back at the past few decades of groundbreaking scientific work in the field. Enjoy! @UTMDAnderson @NatRevImmunol
What an extraordinary time to be in the field of engineered cell therapy!
I am incredibly excited to share our Review, published in @NatRevImmunol, A Guide to CAR T Cell Therapy, written with brilliant immunologists, @RanjanMDPhD and #PamSharma.
This Review is our attempt to tell the story of CAR T cells, from the decades of discoveries in T cell biology that made these therapies possible, through the engineering innovations that transformed them into life-saving treatments, to the clinical milestones, current challenges, and exciting opportunities that lie ahead. We also share our perspectives on several of the most important unanswered questions that we believe will shape the future of the field.
We were honored to dedicate this work to the memory of Zelig Eshhar, whose vision and pioneering work forever changed cancer immunotherapy and continues to inspire generations of scientists and physicians.
A heartfelt thank you to #KirstyMinton and the outstanding editorial team at @NatRevImmunol for their guidance throughout this process.
As both a physician and scientist, I feel incredibly privileged to work in a field where fundamental immunology, bioengineering, and medicine come together with a single purpose: to bring better therapies to patients.
Here's to the science, the collaboration, and to continuing our shared mission of making cancer history. @UTMDAnderson
Karishma Rupani, MD, MMSc retweeted
We look forward to a presentation by @DmitriyZamarin on May 26: "The Wiring of Immune Resistance: Heterogeneity Circuits in #OvarianCancer"
@IcahnMountSinai
Karishma Rupani, MD, MMSc retweeted
Karishma Rupani, MD, MMSc retweeted
Was completely ignorant of the concept that live and healthy cells can WALK INTO another cell, hang out there and then just WALK BACK OUT, without getting harmed!
A short🧵of a phenomenon tying myelofibrosis with Rosai Dorfman disease and autoimmune hepatitis
Karishma Rupani, MD, MMSc retweeted
Review series on clonal hematopoiesis: from CHIP to myeloid neoplasms.
What drives progression from clonal hematopoiesis to myeloid malignancy? This review explores risk, biology, and emerging therapeutic strategies.
haematologica.org/article/vi…
Karishma Rupani, MD, MMSc retweeted
If you were born with ovaries, you’re at risk of ovarian cancer. Know the signs: bloating, loss of appetite, abdominal pain, frequent urination. Listen, speak up, and #AskHer. Questions can lead to early diagnosis and save lives. #WorldOvarianCancerDay
Karishma Rupani, MD, MMSc retweeted
Say it louder for the folks in the back!! I get so mad when I do second opinions for premenopausal patients with node positive disease who were given only tamoxifen because their oncologists told them there “wasn’t a big difference” between tam and OA/AI. There is!!!!!
Ovarian function suppression is arguably the most important advancement for ER+ young women with breast cancer, markedly reducing recurrence.
Now more trials on how to support side effects for these women thrown into early menopause. #bcsm
Karishma Rupani, MD, MMSc retweeted
Reprogramming T cell-myeloid crosstalk overcomes immune resistance in colorectal cancer: Cell Reports Medicine cell.com/cell-reports-medici…
@BhardwajLab @IcahnMountSinai
Karishma Rupani, MD, MMSc retweeted
WATCH: Taiwanese grandmothers aged 89 and 91 train at the gym. An increasing number of elderly people in Taiwan’s super-aged society are hitting the gym to stay healthy, both physically and mentally.
Taiwanese grandmothers aged 89 and 91 train at the gym
Karishma Rupani, MD, MMSc retweeted
Amazing new paper on how diet/ fasting affects T cell function and the impact of the (postprandial) time of cell collection to CART fitness!
teapawt.org/DelgoffeLab/status/204…
Dearest gentle reader, we are delighted to announce a new story from our lab published in @Nature describing how a meal's systemic metabolic changes are interpreted by your immune system to enhance adaptive immunity. A thread 1/ nature.com/articles/s41586-0…
Karishma Rupani, MD, MMSc retweeted
ICYMI: Watch @SaraNunneryMD, and @Neil_Iyengar, discuss the integration of GLP-1 agonists into breast cancer management. @TNOncology @WinshipAtEmory #bcsm #oncology
Prefer to listen? Find the audio on your favorite podcast platforms! 🎧
onclive.com/view/evolving-re…
Karishma Rupani, MD, MMSc retweeted
Today I learned that most of ovarian cancer actually comes from the fallopian tube shedding cells to the ovary, rather than ovarian cells!
Karishma Rupani, MD, MMSc retweeted
How Do Cancer Cells ‘Learn’ to Resist Treatment?
nyulangone.org/news/how-do-c…
Congratulations to @ItaiYanai @nyulangone for his elegant @Nature paper today that made the cover!
nature.com/articles/s41586-0…
@Perlmutter_CC
Karishma Rupani, MD, MMSc retweeted
A new feature @ScienceMagazine on the clusters of cells that enhance the spread of cancer, and what can be done to break them up @ScienceVisuals
science.org/content/article/…
Karishma Rupani, MD, MMSc retweeted
Landmark Paper: in 2002 Silverman et al. published results of the phase III CALGB 9221 trial, showing how azacitidine not only caused sustained improvement in cytopenias but also altered the course of myelodysplastic syndromes.
haematologica.org/article/vi…
Karishma Rupani, MD, MMSc retweeted
Excited to join colleagues in NYC this July 11-12 for the 10th Annual Live Medical Crossfire®: Hematologic Malignancies. This year’s program will focus on navigating complex cases, new therapeutic approaches, and practical strategies you can take back to your clinic. Use code ZEIDAN for free HCP registration.
✅ Join us and register today: tinyurl.com/mur2kuxu
@gotoper_
#MedicalCrossfire #gotoPER #Hematology #Oncology #CancerCare
Among patients with atrial fibrillation at high risk for stroke and bleeding, left atrial appendage closure was not noninferior to medical therapy in reducing the risk of stroke, embolism, major bleeding, or death at 3 years. Full CLOSURE-AF trial results: nejm.org/doi/full/10.1056/NE…
Editorial: Left Atrial Appendage Closure — Another Overused Method in Cardiology? nejm.org/doi/full/10.1056/NE…
Karishma Rupani, MD, MMSc retweeted
Someone suggested I make a table summarizing the video. Here it is!


































